Crispr Therapeutics shares owned by Contrarius Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Contrarius Investment Management
from 13F filings
Historical chart of Contrarius Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Contrarius Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Contrarius Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $37M | 784k | 46.98 |
| 2024-03-31 | $45M | 666k | 68.16 |
| 2023-12-31 | $12M | 183k | 62.60 |
| 2023-09-30 | $10M | 221k | 45.39 |
| 2023-06-30 | $13M | 230k | 56.14 |
More positions owned by Contrarius Investment Management
Block Cl A (SQ)
View all positions for Contrarius Investment Management